These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36878621)

  • 1. Impact of patient ancestry on heterogeneity of Sjögren's disease.
    Beydon M; Seror R; Le Guern V; Chretien P; Mariette X; Nocturne G
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 36878621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-RNP positivity in primary Sjögren's syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement.
    Abbara S; Seror R; Henry J; Chretien P; Gleizes A; Hacein-Bey-Abina S; Mariette X; Nocturne G
    RMD Open; 2019; 5(2):e001033. PubMed ID: 31673417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal tubular acidosis and associated factors in patients with primary Sjögren's syndrome: a registry-based study.
    Zhang Y; Qiao L; Zhang L; Li Q; Yang P; Kong X; Duan X; Zhang M; Li X; Wang Y; Xu J; Wang Y; Hsieh E; Zhao J; Xu D; Li M; Zhao Y; Zeng X
    Clin Rheumatol; 2023 Feb; 42(2):431-441. PubMed ID: 36383239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interstitial lung disease in non-sicca onset primary Sjögren's syndrome: a large-scale case-control study.
    Gao H; Zou YD; Zhang XW; He J; Zhang J; Sun Y; Li ZG
    Int J Rheum Dis; 2018 Jul; 21(7):1423-1429. PubMed ID: 29968329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.
    Mandl T; Marsal J; Olsson P; Ohlsson B; Andréasson K
    Arthritis Res Ther; 2017 Oct; 19(1):237. PubMed ID: 29065905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and risk factors of Raynaud's phenomenon in primary Sjögren's syndrome.
    Lin W; Xin Z; Ning X; Li Y; Ren X; Su Y; Liu M; Guo S; Yang L; Liu Y; Zhang F; Zhang W
    Clin Rheumatol; 2021 Oct; 40(10):4081-4087. PubMed ID: 33914202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active immunological profile is associated with systemic Sjögren's syndrome.
    Martel C; Gondran G; Launay D; Lalloué F; Palat S; Lambert M; Ly K; Loustaud-Ratti V; Bezanahary H; Hachulla E; Jauberteau MO; Vidal E; Hatron PY; Fauchais AL
    J Clin Immunol; 2011 Oct; 31(5):840-7. PubMed ID: 21744183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Male patients with primary Sjögren's syndrome: A distinct clinical subgroup?
    Park Y; Lee J; Park SH; Kwok SK
    Int J Rheum Dis; 2020 Oct; 23(10):1388-1395. PubMed ID: 32918388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in clinical phenotypes of primary Sjögren's syndrome depending on early or late onset.
    Sebastian A; Madej M; Sebastian M; Morgiel E; Wawryka P; Wiland P
    Adv Clin Exp Med; 2021 Nov; 30(11):1141-1146. PubMed ID: 34549557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of faecal calprotectin in primary Sjögren's syndrome is common and associated with concomitant organic gastrointestinal disease.
    Andréasson K; Ohlsson B; Mandl T
    Arthritis Res Ther; 2016 Jan; 18():9. PubMed ID: 26759247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry.
    Dumusc A; Ng WF; James K; Griffiths B; Price E; Pease C; Emery P; Lanyon P; Jones A; Bombardieri M; Sutcliffe N; Pitzalis C; Gupta M; McLaren J; Cooper A; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Barone F; Fisher B; Rauz S; Richards A; Bowman S
    Swiss Med Wkly; 2018; 148():w14588. PubMed ID: 29442344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of clinical features and prognosis in patients with primary Sjögren's syndrome and autoimmune liver disease].
    Chen WQ; Dai XN; Yu Y; Wang Q; Liang JY; Ke YN; Yi CH; Lin J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):886-891. PubMed ID: 33047724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development.
    Goules AV; Argyropoulou OD; Pezoulas VC; Chatzis L; Critselis E; Gandolfo S; Ferro F; Binutti M; Donati V; Zandonella Callegher S; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos T; Mavragani CP; Baldini C; Skopouli FN; Fotiadis DI; De Vita S; Moutsopoulos HM; Tzioufas AG
    Front Immunol; 2020; 11():594096. PubMed ID: 33193443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and laboratory profiles of primary Sjogren's syndrome in a Chinese population: A retrospective analysis of 315 patients.
    Li X; Xu B; Ma Y; Li X; Cheng Q; Wang X; Wang G; Qian L; Wei L
    Int J Rheum Dis; 2015 May; 18(4):439-46. PubMed ID: 25925697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome.
    Sanosyan A; Daien C; Nutz A; Bollore K; Bedin AS; Morel J; Zimmermann V; Nocturne G; Peries M; Guigue N; Gottenberg JE; Van de Perre P; Mariette X; Tuaillon E
    Front Immunol; 2019; 10():1153. PubMed ID: 31191532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of new extra-glandular manifestations or associated auto-immune diseases after establishing the diagnosis of primary Sjögren's syndrome : A long-term study of the Antonius Nieuwegein Sjögren (ANS) cohort.
    Ter Borg EJ; Kelder JC
    Rheumatol Int; 2017 Jul; 37(7):1153-1158. PubMed ID: 28424927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct clinical characteristics of anti-Ro/SSA-negative primary Sjögren's syndrome: data from a nationwide cohort for Sjögren's syndrome in Korea.
    Park Y; Lee J; Koh JH; Sung YK; Lee SS; Choe JY; Shim SC; Kim JM; Kwon SR; Kim HO; Chung SH; Park SH; Kwok SK
    Clin Exp Rheumatol; 2019; 37 Suppl 118(3):107-113. PubMed ID: 31376264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticentromere antibody positive patients with primary Sjögren's syndrome have distinctive clinical and immunological characteristics.
    Liu Y; Guo L; Lin W; Ning X; Liu M; Cao J; Su Y; Zheng X; Li S; Li F; Ren L; Song G
    Clin Exp Rheumatol; 2023 Dec; 41(12):2371-2378. PubMed ID: 36995331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivated SARS-CoV-2 vaccine in primary Sjögren's syndrome: humoral response, safety, and effects on disease activity.
    Pasoto SG; Halpern ASR; Guedes LKN; Ribeiro ACM; Yuki ENF; Saad CGS; da Silva CAA; de Vinci Kanda Kupa L; Villamarín LEB; de Oliveira Martins VA; Martins CCMF; Deveza GBH; Leon EP; Bueno C; Pedrosa TN; Santos REB; Soares R; Aikawa NE; Bonfa E
    Clin Rheumatol; 2022 Jul; 41(7):2079-2089. PubMed ID: 35306594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.